Neogen awards options and PSUs to legal chief
NEOGEN CORP reported equity compensation awards to Chief Legal Officer Stacey Jennifer Evans on August 14, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NEOGEN CORP reported equity compensation awards to Chief Legal Officer Stacey Jennifer Evans on August 14, 2026. She received options to acquire 196,276 shares of common stock at an exercise price of $11.65 per share, expiring August 14, 2036, vesting in equal installments over three years. She also received 38,627 performance stock units, which vest in total at the end of a three-year period, with both positions reported as directly owned after the grants.
Insider Trade Summary
Grant/Award: 234,903 shares
Grant/Award
2 txns
Insider
Stacey Jennifer Evans
Role
Chief Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock (Right to Buy) F1 | 196,276 | $0.00 | $0.00 |
| Grant/Award | Common Stock F2 | 38,627 | $11.65 | $450K |
Holdings After Transaction:
Common Stock (Right to Buy) — 196,276 contracts (Direct);
Common Stock — 38,627 shares (Direct)
Footnotes (2)
- F1. Options vest in equal annual installments on each of the first three anniversary dates of the grants
- F2. PSUs vest in total at the end of the three year anniversary date of the grant
Key Figures
Options granted: 196,276 shares
Option exercise price: $11.65 per share
Option expiration date: August 14, 2036
+5 more
8 metrics
Options granted
196,276 shares
Stock options for common stock granted to Chief Legal Officer on August 14, 2026
Option exercise price
$11.65 per share
Exercise price of options on 196,276 shares of common stock
Option expiration date
August 14, 2036
Expiration date of the 196,276-share option grant
Option vesting schedule
3 years
Options vest in equal annual installments over three years from grant
PSUs granted
38,627 units
Performance stock units tied to common stock granted on August 14, 2026
PSU vesting period
3 years
PSUs vest in total at the end of the three-year anniversary of the grant
Direct holdings after option grant
196,276 derivative shares
Total options directly held by Chief Legal Officer following the grant
Direct holdings after PSU grant
38,627 shares
Common stock underlying PSUs directly held after the grant
Key Terms
Common Stock (Right to Buy), performance stock units, vesting
3 terms
Common Stock (Right to Buy) financial
"security_title is listed as Common Stock (Right to Buy) for the option grant"
performance stock units financial
"PSUs vest in total at the end of the three year anniversary date of the grant"
Performance stock units are a type of company award that grants employees shares of stock only if certain performance goals are met. They motivate employees to work toward specific company achievements, aligning their interests with those of shareholders. For investors, they can influence a company's future stock supply and reflect management’s confidence in reaching key targets.
vesting financial
"Options vest in equal annual installments on each of the first three anniversary dates of the grants"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did NEOG (NEOGEN CORP) grant to its Chief Legal Officer?
NEOGEN CORP granted Chief Legal Officer Stacey Jennifer Evans 196,276 stock options at an exercise price of $11.65 per share and 38,627 performance stock units (PSUs), both reported as directly owned following the August 14, 2026 grants.
What are the terms of the 196,276 stock options reported by NEOG’s Chief Legal Officer?
The reported award consists of options for 196,276 shares of NEOGEN CORP common stock with an exercise price of $11.65 per share. These options vest in equal annual installments over three years and expire on August 14, 2036, according to the disclosure.
How do the 38,627 NEOG performance stock units vest for the Chief Legal Officer?
The filing states that the 38,627 PSUs granted to the Chief Legal Officer vest in total at the end of the three-year anniversary of the grant date. Vesting is therefore cliff-style after three years rather than in annual installments.
Were the NEOG (NEOGEN CORP) equity awards to the Chief Legal Officer made under a Rule 10b5-1 plan?
The disclosure indicates the Rule 10b5-1 checkbox is not marked, so the reported equity grants to the Chief Legal Officer on August 14, 2026 are not identified as made pursuant to a Rule 10b5-1 trading plan in this report.
What are the post-grant holdings reported for NEOG’s Chief Legal Officer in this Form 4?
After the transactions, the Chief Legal Officer is reported to directly hold options covering 196,276 shares of common stock and 38,627 shares of common stock tied to PSUs. These totals match the amounts granted on August 14, 2026 in the filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
